Demystifying Dave: Insights From 5 Analyst Reviews | Nasdaq

Nov 11, 2024 · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $62.2, along with a high estimate of $75.00 and a low estimate …

CouponFollow Extension

$62
OFF

Demystifying Dave: Insights From 5 Analyst Reviews | Nasdaq

1 day from now

Nov 11, 2024 · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $62.2, along with a high estimate of $75.00 and a low estimate …

nasdaq.com

$89.71
OFF

Demystifying Insmed: Insights From 7 Analyst Reviews | Nasdaq

1 day from now

5 days ago · The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $89.71, a high estimate of $105.00, and a low estimate of $74.00.

nasdaq.com

$2.88
OFF

Demystifying Adaptimmune Therapeutics: Insights From 4 Analyst …

1 day from now

1 day ago · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $2.88, along with a high estimate of $3.50 and a low estimate …

benzinga.com

$134.45
OFF

Demystifying Five Below: Insights From 31 Analyst Reviews

1 day from now

Jul 18, 2024 · Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $134.45, with a high estimate of $223.00 and a low estimate of $79.00.

businessinsider.com

$31
OFF

Demystifying ACM Research: Insights From 5 Analyst Reviews

1 day from now

Oct 1, 2024 · Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $31.8, a high estimate of $38.00, and a low estimate of …

nasdaq.com

$89.71
OFF

Demystifying Insmed: Insights From 7 Analyst Reviews

1 day from now

6 days ago · The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $89.71, a high estimate of $105.00, and a low estimate of $74.00. This …

sahmcapital.com

$22.71
OFF

Demystifying Amer Sports: Insights From 7 Analyst Reviews

1 day from now

Nov 20, 2024 · Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $22.71, a high estimate of $26.00, and a low estimate …

benzinga.com

$2.88
OFF

Demystifying Adaptimmune Therapeutics: Insights From 4 Analyst …

1 day from now

1 day ago · Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $2.88, along with a high estimate of $3.50 and a low estimate …

sahmcapital.com

$2
OFF

Demystifying Chegg: Insights From 4 Analyst Reviews - Nasdaq

1 day from now

Nov 14, 2024 · The 12-month price targets, analyzed by analysts, offer insights with an average target of $2.5, a high estimate of $4.00, and a low estimate of $1.50.

nasdaq.com

$64
OFF

Demystifying GitLab: Insights From 15 Analyst Reviews

1 day from now

1 day ago · Demystifying GitLab: Insights From 15 Analyst Reviews. ... Insights from analysts' 12-month price targets are revealed, presenting an average target of $64.0, a high estimate of …

benzinga.com

$233
OFF

Demystifying F5: Insights From 4 Analyst Reviews - Nasdaq

1 day from now

Oct 29, 2024 · In the assessment of 12-month price targets, analysts unveil insights for F5, presenting an average target of $233.5, a high estimate of $246.00, and a low estimate of …

nasdaq.com

$38
OFF

Demystifying Sprout Social: Insights From 5 Analyst Reviews

1 day from now

Nov 11, 2024 · In the assessment of 12-month price targets, analysts unveil insights for Sprout Social, presenting an average target of $38.0, a high estimate of $55.00, and a low estimate of …

benzinga.com

FAQs about Demystifying Dave: Insights From 5 Analyst Reviews | Nasdaq Coupon?

How much should you buy Dave (Dave)?

The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Analysts have set 12-month price targets for Dave, revealing an average target of $58.75, a high estimate of $75.00, and a low estimate of $45.00. ...

How do analysts evaluate Dave's Stock?

Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Dave compared to the broader market. Price Targets: Delving into movements, analysts provide estimates for the future value of Dave's stock. ...

How do analysts respond to Dave?

Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Dave. This information provides a snapshot of how analysts perceive the current state of the company. ...

What makes Dave a good stock?

Net Margin: Dave's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 0.24%, the company showcases strong profitability and effective cost management. Return on Equity (ROE): Dave's ROE stands out, surpassing industry averages. ...

What does Dave Inc do?

Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit, and finding side gigs. Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. ...

Why do analysts'maintain' or 'raise' their stance?

Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Five Below. ...